Ara
Toplam kayıt 21, listelenen: 11-20
Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey
(National Institute of Infectious Diseases, 2021)
Since the first report of COVID-19 in December 2019, little is known about therapeutic usage of hydroxychloroquine in pediatric patients with COVID-19. We retrospectively retrieved data for SARS-CoV-2 PCR positive pediatric ...
COVID-19 and urology: A bibliometric analysis of the literature
(John Wiley and Sons Inc, 2021)
Aim The aims of this research were to analyse the urological literature published during the COVID-19 pandemic and to guide future research. Material and methods Between 2019 and 2021, the Web of Science (WoS) All Databases ...
Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients
(NLM (Medline), 2023)
Introduction: This study determines and compares the concentrations of arginine and methylated arginine products ((asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), n-monomethyl-1-arginine (L-NMMA) and ...
Innate and adaptive immunity during SARS-CoV-2 infection: Biomolecular cellular markers and mechanisms
(MDPI, 2023)
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, other human coronaviruses (hCoVs) exist. Historical ...
The COVID-19 pandemic – How many times were we warned before?
(Elsevier B.V., 2022)
Infectious diseases are known to act in both predictable and unpredictable ways, which leads to the notions of emerging and reemerging infectious diseases. Emerging diseases with their disastrous consequences might be ...
COVID-19 pozitif hastalarda SARS-CoV-2 varyantlarının prevalansı
(DOC Design and Informatics Co. Ltd., 2022)
Amaç: Dünya Sağlık Örgütü (DSÖ) tarafından alfa (B.1.1.7), beta (B.1.351), gamma (P.1), delta (B.1.617.2) ve omic - ron (B.1.1.529) endişe verici varyantlar (“variants of concern – VOCs”) olarak sınıflandırılmıştır. ...
SARS-CoV-2 infection provoking autoimmunity
(Oxford University Press, 2023)
For decades, infections have been recognized as strong stimulators of the immune system and subsequently serve as a trigger for autoimmunity and autoimmune diseases. While infection is a very broad term, infectious agents ...
Mesenchymal stem cell-based COVID-19 therapy: Bioengineering perspectives
(MDPI, 2022)
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Mesenchymal stem cells (MSCs) are currently utilized in clinics for pulmonary inflammatory ...
Preoperative screening for COVID-19: Results from a clinical diagnostic laboratory
(Istanbul University, 2022)
Objective: The study aimed to determine what proportion of Turkiye’s preoperative patient population has tested positive for COVID-19 and to ascertain whether the increasing or decreasing trend in the numbers of positive ...
Evaluation of SARS-CoV-2-positive patients with suspected reinfection
(Multidisciplinary Digital Publishing Institute (MDPI), 2023)
The aim of this study was to investigate the reinfection rates and characteristics of SARS-CoV-2 in individuals with SARS-CoV-2 RNA present in their clinical specimens for COVID-19. Our data from the COVID-19 Laboratory ...